Gift by Rothberg Family Reinforces Yale Coronavirus Response
“Our doctors, nurses, and first responders, and all of our health care workers are saving the lives of people we love. We each need to do everything we can to keep them safe and let them know that we are there for them,” says Jonathan Rothberg.
Yale’s Veteran Virologist Leads a Team to Close the Coronavirus Testing Gap
Marie-Louise Landry, MD, professor of laboratory medicine and of medicine (infectious diseases) and director of Yale’s Clinical Virology Lab, knew that with a concerted effort, her lab could replicate the COVID-19 test used by the Centers for Disease Control and Prevention (CDC) and quickly help expand the country’s testing capabilities.
LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout
In the first 3 years of the LAAO Registry, the Watchman left atrial appendage closure device was implanted with rates of in-hospital safety outcomes that were comparable to those seen in the pivotal trials, despite being used in higher-risk patients, new data show.
Yale Experts Discuss "Caring While Keeping Safe" During the COVID-19 Pandemic
The scientists and clinicians at Yale School of Medicine (YSM) and the Yale New Haven Health System (YNHHS) have performed herculean feats, and also faced daunting obstacles, as they work to tame the COVID-19 pandemic in Connecticut.
Despite battling COVID-19, Yale New Haven oncologist continues treating patients virtually
When Dr. Justin Persico first began experiencing COVID-19 symptoms, his mind immediately went to his patients. As a medical oncologist at Smilow Cancer Hospital Care Center at Trumbull, part of Yale Cancer Center, he was all too aware of the people he treats, who would be at greater risk for exposure to the virus.
Taking Immunosuppressant Drugs to Combat Your Chronic Condition? Stay on Them
People with chronic rheumatic and immune diseases, such as lupus, rheumatoid arthritis, and multiple sclerosis, are helped daily by taking a class of drugs that suppress their immune system. Called disease-modifying anti-rheumatic drugs (DMARDs), these agents purposely affect the immune system to reduce the many problematic symptoms of autoimmune diseases, including pain. But does the benefit of immune modulation or suppression in these individuals become a liability during the novel coronavirus pandemic? Many patients are wondering if they are at increased risk of contracting the COVID-19 infection or at increased risk of more severe illness because of their autoimmune disease or because of the DMARDs they are on to treat it. The short answer is, no one knows for sure. The longer answer is, in the absence of solid evidence, these seemingly higher-risk patients are not alone to grapple with uncertainty on their own, but they can and should turn to their physician for clear guidance.